CVR: 43237381
Secondary names: Walmar Consulting ApS
DKK 1,847,721
Gross profit
Net result: DKK 527,965
26c Holding ApS
CVR · view ownership and management
Owner registered: 26c Holding ApS
CVR · 15/03/2023
View the full event history
Walmar Clinical ApS is a Danish company of the type Anpartsselskab based in Snekkersten, founded in 2022. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Mikkel Walmar. The company is owned by 26c Holding ApS. In 2025, the company reported a gross profit of DKK 1,847,721 and a net result of DKK 527,965 compared with DKK 623,346 the year before. Equity in the 2025 report amounted to DKK 932,122.
Source: annual report 2025, Danish Business Authority
Walmar Clinical ApS demonstrates a stable financial health with consistent gross profit and profit figures over the last three fiscal years. Gross profit has remained relatively steady, with 1,909,543 DKK in 2023, slightly decreasing to 1,847,721 DKK in 2025, while profit has shown a declining trend from 725,164 DKK in 2023 to 527,965 DKK in 2025. The company's equity position has improved significantly from 666,157 DKK in 2024 to 932,122 DKK in 2025, indicating a strengthening balance sheet. However, the absence of revenue data raises concerns about the company's market position and growth potential within the research and experimental development sector.
AI-generated summary · Generated 16/08/2026
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Source: annual reports filed with the Danish Business Authority.
Compared to 1.041 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringWalmar Clinical ApS was founded on 3 May 2022.
Walmar Clinical ApS is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (industry code 721000).
Walmar Clinical ApS is owned by 26c Holding ApS.
In 2025, Walmar Clinical ApS reported a gross profit of DKK 1,847,721.
The management of Walmar Clinical ApS consists of Mikkel Walmar.
Walmar Clinical ApS is located at Stolbjergvej 26C, 3070 Snekkersten.
Claim this page to add your logo and social links. Free to get started.
Walmar Clinical ApS has published its annual report for 2025. Gross profit came to DKK 1,847,721, and the net result was DKK 527,965.
Walmar Clinical ApS has published its annual report for 2024. Gross profit came to DKK 1,946,435, and the net result was DKK 623,346.
Walmar Clinical ApS has published its annual report for 2023. Gross profit came to DKK 1,909,543, and the net result was DKK 725,164.
Walmar Clinical ApS has published its interim report for the period May 3, 2022 – December 31, 2022.
As of March 15, 2023, 26c Holding ApS is registered as an owner of Walmar Clinical ApS with an ownership share of 100%.
As of May 3, 2022, Mikkel Walmar is registered as director of Walmar Clinical ApS.
Walmar Clinical ApS was founded on May 3, 2022.
Companies in the same industry and area
CVR 32071511
CVR 37882240
CVR 28938799
CVR 35532900
CVR 35860177
